Ignite Creation Date:
2025-12-24 @ 4:31 PM
Ignite Modification Date:
2025-12-26 @ 8:26 AM
Study NCT ID:
NCT05596266
Status:
UNKNOWN
Last Update Posted:
2022-10-27
First Post:
2022-10-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CD5 CAR-T Therapy for Refractory/Relapsed CD5+ T-cell Acute Lymphoblastic Leukemia
Sponsor:
Xuanwu Hospital, Beijing
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-25
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10-25
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-23
First Submit QC Date:
None
Study First Post Date:
2022-10-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-23
Last Update Post Date:
2022-10-27
Last Update Post Date Type:
ACTUAL